CJJClass I

Diazo, Alt/Sgpt

21 CFR 862.1030 / Clinical Chemistry

CJJ is the FDA product code for Diazo, Alt/Sgpt, a class I device type, regulated under 21 CFR 862.1030. As of 2026-09-10, FDA records hold 2 510(k) clearances under this code, the most recent dated 1994-12-09, and no recalls.

Classification record

Product code: CJJ
Device name: Diazo, Alt/Sgpt
Regulation: 21 CFR 862.1030
Device class: Class I
Review panel: Clinical Chemistry
Submission type: 510(k) exempt
Implant: No
Life sustaining or supporting: No
GMP exempt: No
Third party review eligible: No
Ingested clearances: 2
Ingested recalls: 0

Clearances, product code CJJ

By decision year

2 clearances under product code CJJ with a decision year between 1989 and 1994, 1989 the highest year at 1.

Show the numbers

510(k) clearances under FDA product code CJJ by decision year
Year	Clearances
1989	1
1994	1

Applicants with the most clearances

Product code CJJ

Applicants holding the most 510(k) clearances under product code CJJ
Applicant	Clearances
Biotrack, Inc.	1
Prisma Systems	1

Companies listing this code with FDA

Companies whose registered establishments list this code

Sanzay Corporation

Recent clearances

Product code CJJ

Recent recalls

Product code CJJ

FDA records show no recalls under product code CJJ.

MDM coverage of this record lists here, newest first.

About this record

Sourced from the FDA device classification database, ingested from openFDA. The definition, regulation number, device class and review panel are FDA’s own fields, reproduced without editing.

MDM adds the counts: clearances by decision year, the applicants holding the most clearances under this code, recalls that name it, and the registered establishments that list it. Every count is computed from ingested records only.

Data as of 2026-10-05, the FDA export date for this dataset. Page last changed 2026-09-05. View this product code on fda.gov (opens on fda.gov)